Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132610) titled 'A Phase II, Single-Arm, Single-Center Clinical Trial of Vebreltinib Enteric Capsules in Combination with Bevacizumab and Temozolomide in Patients with Recurrent/Progressive High-Grade Glioma' on Sept. 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Chinese People's Liberation Army
Condition:
High grade glioma
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2026-09-09
Target Sample Size: Single-arm experimental group:50;
Countries of Recruitment:
china
To know more, visit http...